Cobroxin: Breakthrough in The Treatment of Pain

Rik J. Deitsch

View All Contributions By:  

Job Title / Position: Chief Executive Officer of Nutra Pharma Corp.

Website:

Contact Information:


In this recording, Nutra Pharma’s Chairman and CEO, Rik J Deitsch explores the science behind Cobroxin, a revolutionary new pain killer and shows how Cobroxin will change the way chronic pain is treated in America and abroad. Unlike many popular pain medicines, Cobroxin does not rely on opiates or acetaminophen for its pain relieving effects, thus significantly reducing the risk of dependence, addiction and toxic effects on vital organs. Instead, it uses small peptides from the venom of one of the deadliest animals on Earth – the cobra.

We are all familiar with the dangers of long-term use of traditional pain killers, ranging from liver damage to dependence and addiction …and yet, for many, it can be difficult, even impossible to function without them.

Over 50 million Americans suffer from ongoing, unremitting chronic pain, but there may be some good news. In August of last year, a biotechnology company, Nutra Pharma (www.nutrapharma.com) announced the launch of Cobroxin, a safe and effective over-the-counter treatment for chronic pain. Unlike many popular pain medicines, Cobroxin does not rely on opiates or acetaminophen for its pain relieving effects, thus significantly reducing the risk of dependence, addiction and toxic effects on vital organs. Instead, it uses small peptides from the venom of one of the deadliest animals on Earth – the cobra.

In this presentation, Nutra Pharma’s Chairman and CEO, Rik J Deitsch explores the science behind this revolutionary new pain killer and shows how Cobroxin will change the way chronic pain is treated in America and abroad.

[i4w_onlyfor tagid=’507,456,242′]

Breakthroughs in the Treatment of Pain

[ELSE_onlyfor]

Log In or Click Here to View Presentation

[/i4w_onlyfor]

Leave a Comment